Abstract
Lung cancer is the neoplasia responsible for the highest number of deaths in Brazil and worldwide. Several therapeutic approaches for non-small cell lung cancer (NSCLC), its most common type, are based on chemotherapy with combinations of cisplatin, a drug with cytotoxic potential that acts by causing DNA damage. However, the efficacy of cisplatin is limited due to the development of tumo…